Mouse models for hepatitis B virus research

Abstract Hepatitis B virus (HBV) infection remains a major global health problem; indeed, there are 250 million carriers worldwide. The host range of HBV is narrow; therefore, few primates are susceptible to HBV infection. However, ethical constraints, high cost, and large size limit the use of prim...

Full description

Bibliographic Details
Main Authors: Jeong-Ryul Hwang, Sung-Gyoo Park
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Laboratory Animal Research
Subjects:
FRC
Online Access:http://link.springer.com/article/10.5625/lar.2018.34.3.85
id doaj-4dc218e467ae48cfb4bbd916e0b6e7b1
record_format Article
spelling doaj-4dc218e467ae48cfb4bbd916e0b6e7b12020-11-25T00:18:32ZengBMCLaboratory Animal Research2233-76602018-12-01343859110.5625/lar.2018.34.3.85Mouse models for hepatitis B virus researchJeong-Ryul Hwang0Sung-Gyoo Park1School of Life Sciences, Cwangju Institute of Science and Technology (CIST)School of Life Sciences, Cwangju Institute of Science and Technology (CIST)Abstract Hepatitis B virus (HBV) infection remains a major global health problem; indeed, there are 250 million carriers worldwide. The host range of HBV is narrow; therefore, few primates are susceptible to HBV infection. However, ethical constraints, high cost, and large size limit the use of primates as suitable animal models. Thus, in vivo testing of therapies that target HBV has been hampered by the lack of an appropriate in vivo research model. To address this, mouse model systems of HBV are being developed and several are used for studying HBV in vivo. In this review, we summarize the currently available mouse models, including HBV transgenic mice, hydrodynamic injection-mediated HBV replicon delivery systems, adeno-associated virus-mediated HBV replicon delivery systems, and human liver chimeric mouse models. These developed (or being developed) mouse model systems are promising and should be useful tools for studying HBV.http://link.springer.com/article/10.5625/lar.2018.34.3.85Hepatitis B virusmouse modelalb-uPA/SCIDFRC
collection DOAJ
language English
format Article
sources DOAJ
author Jeong-Ryul Hwang
Sung-Gyoo Park
spellingShingle Jeong-Ryul Hwang
Sung-Gyoo Park
Mouse models for hepatitis B virus research
Laboratory Animal Research
Hepatitis B virus
mouse model
alb-uPA/SCID
FRC
author_facet Jeong-Ryul Hwang
Sung-Gyoo Park
author_sort Jeong-Ryul Hwang
title Mouse models for hepatitis B virus research
title_short Mouse models for hepatitis B virus research
title_full Mouse models for hepatitis B virus research
title_fullStr Mouse models for hepatitis B virus research
title_full_unstemmed Mouse models for hepatitis B virus research
title_sort mouse models for hepatitis b virus research
publisher BMC
series Laboratory Animal Research
issn 2233-7660
publishDate 2018-12-01
description Abstract Hepatitis B virus (HBV) infection remains a major global health problem; indeed, there are 250 million carriers worldwide. The host range of HBV is narrow; therefore, few primates are susceptible to HBV infection. However, ethical constraints, high cost, and large size limit the use of primates as suitable animal models. Thus, in vivo testing of therapies that target HBV has been hampered by the lack of an appropriate in vivo research model. To address this, mouse model systems of HBV are being developed and several are used for studying HBV in vivo. In this review, we summarize the currently available mouse models, including HBV transgenic mice, hydrodynamic injection-mediated HBV replicon delivery systems, adeno-associated virus-mediated HBV replicon delivery systems, and human liver chimeric mouse models. These developed (or being developed) mouse model systems are promising and should be useful tools for studying HBV.
topic Hepatitis B virus
mouse model
alb-uPA/SCID
FRC
url http://link.springer.com/article/10.5625/lar.2018.34.3.85
work_keys_str_mv AT jeongryulhwang mousemodelsforhepatitisbvirusresearch
AT sunggyoopark mousemodelsforhepatitisbvirusresearch
_version_ 1725375978967924736